Reeovision

Company Overview

Snapshot

Founded in January 2023 by Ronen Einat and Yaniv Barkana, Reeovision operates with 1–10 employees. The company has secured funding across one round, raising a total of $25K. Reeovision is currently in the Pre-Funding stage, focusing on developing its innovative medical imaging technology.

Business overview

Reeovision is pioneering advancements in medical imaging, specifically targeting the ophthalmology sector. The company's core technology involves developing the first commercial Optical Coherence Tomography (OCT) device that integrates full-volume 3D mapping with other imaging modalities. This approach aims to provide high-resolution, full-field OCT analysis, outperforming current tools by offering a smaller, more cost-effective device with multi-modality data capture. Reeovision's solution enhances diagnostic quality for conditions like Glaucoma, Age-related Macular Degeneration (AMD), and diabetic retinopathy, operating within the Health Tech & Life Sciences sector, with a focus on medical devices and diagnostics.

Company Intelligence Q&A

When was Reeovision founded?

Reeovision was founded in January 2023.

Who are the founders of Reeovision?

The founders of Reeovision are Ronen Einat and Yaniv Barkana.

What is Reeovision's primary focus?

Reeovision's primary focus is on making a breakthrough in medical imaging by developing the first commercial Optical Coherence Tomography (OCT) device that delivers full-volume 3D mapping along with other imaging modalities, particularly for ophthalmology.

What kind of technology does Reeovision utilize?

Reeovision utilizes full-field imaging techniques for Optical Coherence Tomography (OCT) analysis, enabling high-resolution 3D information of surface structure and internal depth of transparent materials and tissues.

What is the current employee size of Reeovision?

Reeovision currently has 1–10 employees.